Startups
Curebase is reinventing decentralized clinical trials to help the vast majority of potential patients that currently cannot access clinical research. Curebase’s vision is that any patient, no matter where they are located, should be able to participate in clinical trials at home and with their own doctors. This is made possible through a unique suite of tools, including all-in-one eClinical software and virtual research sites, designed to engage patients in clinical trials across all settings, be it at home, at their local clinic, or other places in their community.
Overview
Location
United States, California, San Francisco
Employees
51-200
Total raised
$55M
Founded date
2017
Investors 13
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
| Jun 16, 2021 | Synetro Group | synetro.com |
| Positive Sum | positivesumvc.com | |
| Bold Capital Partners | boldcapitalpartners.com | |
| Jun 26, 2022 | Breyer Capital | breyercapital.com |
| Apr 26, 2021 | Y Combinator | ycombinator.com |
| Xfund | xfund.com | |
| C3 Ventures | c3.ventures | |
| Positive Sum | positivesum.com | |
| Dec 10, 2022 | GGV Capital | ggvc.com |
Show more
Funding Rounds 2
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
| May 25, 2021 | Series A round | $15M |
Mentions in press and media 23
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Dec 17, 2024 | Closed Loop Medicine demonstrates application of digital platform for remote blood pressure and medication monitoring | Study published in JMIR validates the feasibility, use and safety of a digital platform for remote, routine monitoring of blood pressure and medication in hypertension patients Findings support the use of the Company’s combined drug + digit... |
| Jan 27, 2023 | Curebase Launches Remote First DTx Research Platform | What You Should Know: This unique blend of eClinical software and technology-driven services enables sponsors of DTx studies to leverage the following Curebase capabilities: Technology and virtual site models: The company’s fit-for-purpose ... |
| Sep 21, 2022 | Meru Health recruits Curebase for mental health clinical trial | The companies are partnering on a 3 year long trial to measure the effectiveness of Meru's treatment There are many companies in the mental health space right now, all vying for dollars and attention, so all of them need to have some kind o... |
| Sep 2, 2022 | Medable rolls out new decentralized trial software for speedier vaccine development | Medable is arguably the strongest company in the decentralized clinical trials space. If fundraising is any measure of success, the company has raised more than $521 million since its founding in 2012 — significantly more than its competito... |
| May 5, 2022 | WIth the goal of expanding access to clinical trials, Curebase raises $40M | The company added Gilead as a strategic investor While all the ways that COVID affected healthcare remain to be seen, the system has already begun to respond to some of the inequities and inefficiencies that were exposed during the pandemic... |
| May 5, 2022 | Sequoia, Andreessen Horowitz, a Saudi prince, and other investors have agreed to pour $7.1B into Elon Musk’s deal for Twitter | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox. There’s nothing like a good SEC filing to wake a person up in the morning. Paid Content How does ... |
| May 5, 2022 | Curebase thinks the future of clinical testing is decentralized, and raises $40M to prove it | The medical world has come a long way from the traditional, centralized way of conducting clinical trials, but there’s still a lot of modernization left to do. Curebase provides the infrastructure — physical and digital — for distributed cl... |
| May 5, 2022 | Curebase Raises $40M in Series B Funding | Curebase, a San Francisco, CA-based technology-driven clinical trial startup, raised $40m in Series B funding. The round was led by Industry Ventures, with participation from Acrew Capital, World Innovation Lab and Positive Sum, Gaingels, G... |
| May 5, 2022 | Clinical trial startup Curebase bags $40 million in Series B funding to democratize access to clinical studies | One of the lessons learned from the covid pandemic is how research institutions, governments, and pharmaceutical companies worked together to develop efficient vaccines to cure the deadly coronavirus. The pandemic is also a reminder of the ... |
Show more
Reviews 0
FAQ about Curebase
When was Curebase founded?
Curebase was founded in 2017.
How much funding has Curebase raised?
Curebase has raised $55M in total across 2 funding rounds.
What funding rounds has Curebase raised?
Parsers VC lists 2 funding rounds of Curebase, among them a Series A round of $15M on May 25, 2021.
Who has invested in Curebase?
Parsers VC lists 13 investors of Curebase, among them GGV Capital, Breyer Capital and Synetro Group.
What has the press written about Curebase?
Parsers VC has collected 23 articles mentioning Curebase, among them “Closed Loop Medicine demonstrates application of digital platform for remote blood pressure and medication monitoring” (Dec 17, 2024) and “Curebase Launches Remote First DTx Research Platform” (Jan 27, 2023).
Is Curebase still active?
Yes, Curebase is active; its latest activity on Parsers VC dates from Dec 22, 2024.